Mon, May 11, 2020

David Risinger Initiated (ABBV) at Buy and Held Target at $95 on, May 11th, 2020

David Risinger of Morgan Stanley, Initiated "AbbVie Inc." (ABBV) at Buy and Held Target at $95 on, May 11th, 2020.

David has made no other calls on ABBV in the last 4 months.



There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Monday, March 23rd, 2020


These are the ratings of the 4 analyists that currently disagree with David


  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $98 on, Monday, May 4th, 2020
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $101 on, Monday, May 4th, 2020
  • Navin Jacob of "UBS" Maintained at Strong Buy with Decreased Target to $96 on, Monday, April 13th, 2020
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $105 on, Tuesday, February 18th, 2020